AJCN Yamada Bee Farm Grant for Honeybee Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeFronzo, R. A.
Right arrow Articles by Felig, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeFronzo, R. A.
Right arrow Articles by Felig, P.
Agricola
Right arrow Articles by DeFronzo, R. A.
Right arrow Articles by Felig, P.

American Journal of Clinical Nutrition, Vol 33, 1378-1386, Copyright © 1980 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Amino acid metabolism in uremia: insights gained from normal and diabetic man

RA DeFronzo and P Felig

The physiology of the interorgan exchange of amino acids in healthy subjects and in insulin-dependent diabetics is reviewed and compared with changes observed in patients with chronic renal failure. In contrast to the diabetic, who has elevated fasting branched-chain amino acid levels and diminished muscle uptake of branched-chain amino acid following protein feeding, fasting levels of leucine, isoleucine, and valine are decreased in uremia. Furthermore, the decline in branched- chain amino acids following insulin in normal and intracellular levels of leucine and isoleucine have been reported to be normal. With respect to alanine metabolism, the diabetic state is characterized by diminished fasting alanine levels which are due to a 2-fold increase in splanchnic alanine extraction. Accordingly, gluconeogenesis can potentially account for over 30 to 40% of hepatic glucose production compared to 15 to 20% in normal man. In uremia, fasting alanine levels are normal and hepatic alanine uptake is not increased. Similarly, basal hepatic glucose production, as well as suppression of glucose production following insulin, are normal in uremic subjects. Thus, although uremia is characterized by abnormalities in the metabolism of many individual amino acids, it does not appear to share the same disturbances in alanine and branched-chain amino acid metabolism that are associated with insulin deficiency.


This article has been cited by other articles:


Home page
The Diabetes EducatorHome page
M. J. Franz
Protein, Diabetes, and Nephropathy
The Diabetes Educator, January 1, 1997; 23(5): 535 - 543.
[PDF]


Home page
JPEN J Parenter Enteral NutrHome page
W. W. Souba
Review: Interorgan Ammonia Metabolism in Health and Disease: A Surgeon's View
JPEN J Parenter Enteral Nutr, November 1, 1987; 11(6): 569 - 579.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
W. W. Souba, R. J. Smith, and D. W. Wilmore
Glutamine Metabolism by the Intestinal Tract
JPEN J Parenter Enteral Nutr, September 1, 1985; 9(5): 608 - 617.
[PDF]


Home page
JPEN J Parenter Enteral NutrHome page
J. Takala
Total Plasma Clearance of Intravenous Essential Amino Acids: Evidence of Abnormal Metabolism of Amino Acids in Chronic Renal Failure
JPEN J Parenter Enteral Nutr, March 1, 1983; 7(2): 146 - 150.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by The American Society for Nutrition